tiprankstipranks
Trending News
More News >
Cellectar Biosciences (CLRB)
NASDAQ:CLRB
US Market
Advertisement

Cellectar Biosciences (CLRB) Financial Statements

Compare
1,431 Followers

Cellectar Biosciences Financial Overview

Cellectar Biosciences's market cap is currently $17.62M. The company's EPS TTM is $-3.39; its P/E ratio is ―; Cellectar Biosciences is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $-2.53. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Cellectar Biosciences Earnings and Revenue History

Cellectar Biosciences Debt to Assets

Cellectar Biosciences Cash Flow

Cellectar Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis